Ex Parte Foley et alDownload PDFPatent Trial and Appeal BoardOct 14, 201411416892 (P.T.A.B. Oct. 14, 2014) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE __________ BEFORE THE PATENT TRIAL AND APPEAL BOARD __________ Ex parte KEVIN T. FOLEY and ROY LIM __________ Appeal 2012-005177 Application 11/416,892 Technology Center 3700 __________ Before LORA M. GREEN, JEFFREY N. FREDMAN, and ULRIKE W. JENKS, Administrative Patent Judges. PER CURIAM DECISION ON APPEAL This is a decision on appeal1 under 35 U.S.C. § 134 from the Examiner’s rejection of claims 1, 2, 5–10, 12–14, 19, 20, 23, and 24.2 We have jurisdiction under 35 U.S.C. § 6(b). We affirm. 1 The Real Party in Interest is Warsaw Orthopedic, Inc. (App. Br. 2). 2 Claim 11 is also pending (App. Br. 2), but the Examiner has withdrawn the rejection of that claim (Ans. 4). Appeal 2012-005177 Application 11/416,892 2 STATEMENT OF THE CASE The Specification discloses “methods and devices to increase the disc height between adjacent vertebral members” (Spec. 1, ¶ 0004). Claim 1 is representative of the claims on appeal and reads as follows: 1. A method of spacing vertebral members within a patient comprising the steps of: inserting a spacer through a cannula and into a disc space between the vertebral members while the spacer is positioned at a first end of a delivery device and a deploying mechanism is positioned at a second end of the delivery device, the spacer is contained within a sheath and an end of the sheath is positioned on an exterior of the patient and the deploying mechanism is positioned outside of the sheath; expanding a height of the spacer with the deploying mechanism to increase a distance between the vertebral members to form a disc height; inserting a material in a first form into the disc space; changing the material to a second form that is more viscous than the first form; and after the material changes to the second form that maintains the disc height, reducing the height of the spacer and removing the spacer from the disc space. Issue The Examiner has rejected claims 1, 2, 5–10, 12–14, 19, 20, 23, and 24 under 35 U.S.C. § 103(a) as obvious over the combination of Felt,3 Cantu,4 Slater,5 and Manzi6 (Ans. 5–8).7 We focus our initial analysis on independent claim 1. 3 Felt et al., US 6,248,131 B1, Jun. 19, 2001. 4 Cantu, US 2006/0235423 A1, Oct. 19, 2006. 5 Slater et al., US 5,347,995, Sept. 20, 1994. 6 Manzi et al., US 2005/0182414 A1, Aug. 18, 2005. Appeal 2012-005177 Application 11/416,892 3 The issue presented is: Has the Examiner established by a preponderance of the evidence that the combination of Felt, Cantu, Slater, and Manzi would have made obvious a method of spacing vertebral members within a patient comprising the step of “inserting a spacer through a cannula and into a disc space between the vertebral members . . . [wherein] the spacer is contained within a sheath and an end of the sheath is positioned on an exterior of the patient,” as required by claim 1? Findings of Fact FF1. The Examiner finds that Felt discloses a “method of spacing vertebral members by inserting an inflatable device in a disc space between adjacent vertebrae and filling the device with a gas to inflate . . . the device and distract the disc space” (Ans. 5 (citing Felt at col. 5, ll. 48–50)). FF2. The Examiner finds that once the Felt device is inflated, “a first biomaterial is delivered to [a] perimeter of the annular space and cured” (id. (citing Felt at col. 6, ll. 23–26 and 30–32)). FF3. The Examiner finds that Felt “fails to disclose the use of a spacer that is contained within a sheath with an end of the sheath positioned outside of the patient to expand the height of the disc space” (id. at 5–6). FF4. The Examiner finds that Cantu discloses “a spacer for maintaining disc height during [a] disc or nucleus procedure” (id. at 6 (citing Cantu at ¶ 0025)). 7 The Examiner’s statement of the rejection included claims 15, 17, 18, and 21 (Ans. 5), but Appellants indicate that these claims have been canceled (App. Br. 2). Appeal 2012-005177 Application 11/416,892 4 FF5. The Examiner finds that Cantu’s “device can be fully wrapped in a sheath 146 to prevent unwanted biological material from entering into the spacer device” (id. (citing Cantu at ¶ 0039)). FF6. The Examiner finds that Cantu’s mechanical spacer “provides a more controlled distraction means as compared to [an] inflatable device” (id.). FF7. Cantu discloses medical devices “that can be used for a variety of medical procedures such as a medical procedure to alter the height of a vertebral body” (Cantu 1, ¶ 0001). FF8. Figure 2 of Cantu is shown below: Figure 2 shows “an exploded view of a medical device” (id. at 1, ¶ 0007). FF9. Cantu discloses that the “[m]edical device 120 includes a link assembly 122 . . . and an actuating member 124 configured to couple to link assembly 122” (id. at 3, ¶ 0033). FF10. Cantu discloses that, “[i]n use, the link assembly 122 in a collapsed configuration, actuating member 124, first member 126 and second member 128 are passed through the cannula 138 to a selected location within a body of a patient, such as a vertebra” (id. at 4, ¶ 0043). App App Figu optio inclu wrap from 120” shea the p med wher exten (citin to us eal 2012-0 lication 11 FF11. F re 5 shows nal wrap FF12. C de a wrap 146 is a p entering i (id. at 4, ¶ FF13. T th . . . exte atient” (A FF14. T ical device ein the op ds along t g Slater a FF15. T e and inex 05177 /416,892 igure 5 of “an assem 146” (id. a antu discl 146 that c rotective c nto the lin 0039). he Examin nds to the ns. 6). he Examin 70 . . . [w en end rec he device t col. 1, ll. he Examin pensive de Cantu is s bled view t 3, ¶ 0033 oses that “ ollectively overing th k assembl er finds th exterior of er finds th herein the eives a dis and cover 40–43)). er finds th vice [that 5 hown belo of the me ). [m]edical encases t at prevent y 122 duri at “Cantu a patient at Slater d ] sheath ha tal end of s at least a at Slater’s ] ensures t w: dical devi device 120 he link ass s unwante ng use of t fails to di when the d iscloses a s an open the device portion of sheath “p hat the por ce 120 . . may opti embly 122 d biologic he medica sclose that evice is in “sheath 1 end and a 70 and th the handl rovides fo tion of the . with an onally . . . The al materia l device the serted int 0 for a closed end e sheath e 76” (id. r an easy device l o Appeal 2012-005177 Application 11/416,892 6 that is inserted into the body is sterile” (id. (citing Slater at col. 1, ll. 32– 34)). FF16. Slater discloses that a “laryngoscope is a device that is used by a physician to examine a patient’s throat . . . [and] consists generally of a blade movably attached to a cylindrically shaped handle” (Slater, col. 1, ll. 11–14). FF17. Slater discloses that it is “important that a laryngoscope blade remain sterile in order to prevent the transmission of serious diseases . . . . This fact led to the development of disposable laryngoscope blade covers” (id. at col. 1, ll. 21–26). FF18. Slater discloses “a disposable laryngoscope blade cover that includes a flexible sleeve and a resilient slide band for use in conjunction with a laryngoscope having a blade and a handle” (id. at col. 1, ll. 37–39). FF19. Slater discloses that the “sleeve has an open end and a closed end. The open end is received by the blade and the handle. The sleeve covers the blade and at least a portion of the handle” (id. at col. 1, ll. 40–43). FF20. The Examiner concludes that, in view of Cantu and Slater, it would have been obvious to one skilled in the art to perform Felt’s method with the use of a spacer that is contained within a sheath . . . so that the sheath extends to the exterior of a patient . . . and the deploying mechanism is positioned outside of the sheath . . . in order to provide a controlled means of distraction . . . while providing a cheap and easy to use device to maintain a sterile environment. (Id. at 6–7.) Appeal 2012-005177 Application 11/416,892 7 FF21. The Examiner relies on Manzi and Manzi’s incorporation by reference of U.S. Patent No. 6,595,998 to meet dependent claim limitations (id. at 7–8 and 9). Principles of Law “The combination of familiar elements according to known methods is likely to be obvious when it does no more than yield predictable results.” KSR Int’l Co. v. Teleflex Inc., 550 U.S. 398, 416 (2007). If a person of ordinary skill can implement a predictable variation, § 103 likely bars its patentability. For the same reason, if a technique has been used to improve one device, and a person of ordinary skill in the art would recognize that it would improve similar devices in the same way, using the technique is obvious unless its actual application is beyond his or her skill. Id. at 417. In determining whether obviousness is established by combining the teachings of the prior art, “the test is what the combined teachings of the references would have suggested to those of ordinary skill in the art.” In re Keller, 642 F.2d 413, 425 (CCPA 1981). Analysis Appellants argue that the cited references do not disclose or suggest, inserting “a sheathed object through a cannula and into a patient with the end of the sheath remaining on the exterior of the patient” (App. Br. 6). Appellants argue that although Cantu discloses that a “spacer and wrap may be inserted into the patient through a cannula . . . [t]he wrap is completely positioned in the patient and a distal end is not positioned on an exterior of the patient” (id. at 7). Appellants argue that although “Slater discloses a Appeal 2012-005177 Application 11/416,892 8 laryngoscope that includes a blade that is inserted into the throat, and a handle that is grasped by the doctor . . . [wherein a] cover extends over the blade and along a section of the handle,” the laryngoscope is not used with a cannula (id.). Appellants argue that Slater’s laryngoscope “includes an enlarged size that would not appear to be applicable for insertion through a cannula” (id.). Appellants argue that, upon reviewing the cited references, one of ordinary skill in the art “would not recognize that a device in a sheath can be inserted into a patient through a cannula with a portion of the sheath remaining on an exterior of a patient” (id.). Appellants’ arguments are not persuasive. Cantu discloses medical devices that can be used to alter the height of a vertebral body, wherein the medical device includes a wrap or protective covering that encases the mechanically operative part of the device that is placed within the body to prevent to prevent biological material from entering the device during use (FFs 7, 11, and 12). Slater discloses a medical device, i.e. a laryngoscope, which includes a flexible sleeve cover that covers the blade and at least a portion of the handle for the purpose of maintaining sterility of the device (FFs 17–19). “[T]he test is what the combined teachings of the references would have suggested to those of ordinary skill in the art.” In re Keller, 642 F.2d 413, 425 (CCPA 1981). We, thus, agree with the Examiner that it would have been obvious to the ordinary artisan that, in view of Slater, Cantu’s device wrap could be modified to be a protective sleeve that extends outside the body to thereby serve both purposes of protecting the device and providing sterility of the device, and also to facilitate the ease of application of a protective covering to the Cantu device. Appeal 2012-005177 Application 11/416,892 9 Appellants’ argument that, in view of the references, one of ordinary skill in the art would not recognize that a sheathed device could be inserted into a patient through a cannula, with a sheath portion remaining exterior to the patient, is also not persuasive. Cantu discloses that a sheathed device is deployed through a cannula (FFs 10 and 12) and using a sheath that extends outside the body and outside the cannula would not only provide device protection and sterility, as discussed above, but would also ensure that the sheath could be removed from the cannula along with the device. Thus, we affirm the rejection of claim 1 as being obvious over the combination of Felt, Cantu, Slater, and Manzi. Claims 2 and 5–9 have not been argued separately from claim 1, and, therefore, fall with that claim. 37 C.F.R. § 41.37(c)(1)(vii). Appellants also argue the rejection of independent claim 10. Claim 10 is directed to a method of spacing vertebral members comprising, among other steps, the steps of “extending the sheath over the spacer and over a limited portion of an elongated member attached to the spacer; inserting the spacer and the sheath through a cannula and into a disc space between the vertebral members with the opening of the sheath positioned on the exterior of the patient” (emphasis added).8 Appellants argue that “there is no disclosure or suggestion in any of the references, either alone or in combination, to insert a sheathed object through a cannula and into a patient with the end of the sheath remaining on the exterior of the patient” (App. Br. 9). Appellants argue that, “[f]or at least 8 The full text of claim 10 can be found in the Claims Appendix to the Appeal Brief (App. Br. 12). Appeal 2012-005177 Application 11/416,892 10 this reason, independent claim 10 is not made obvious” over the combination of the cited references (id.). Appellants’ argument is not persuasive for the reasons discussed above. Thus, we affirm the rejection of claim 10 as being obvious over the combination of Felt, Cantu, Slater, and Manzi. Claims 12–14 have not been argued separately from claim 10, and therefore, fall with that claim. 37 C.F.R. § 41.37(c)(1)(vii). Appellants also argue the rejection of independent claim 19. Claim 19 is directed to a method of spacing vertebral members comprising, among others, “the steps of: inserting a spacer and a portion of an insertion member into a sheath; inserting the spacer within the sheath into a disc space between the vertebral members while a portion of the sheath is positioned on an exterior of the patient” (emphasis added).9 Appellants argue that “there is no disclosure or suggestion in any of the references, either alone or in combination, to insert a sheathed object through a cannula and into a patient with the end of the sheath remaining on the exterior of the patient” (App. Br. 9). Appellants argue that, “[f]or at least this reason, independent claim 19 is not made obvious” over the combination of the cited references (id.). Appellants’ argument is not persuasive for the reasons discussed above. Thus, we affirm the rejection of claim 19 as being obvious over the combination of Felt, Cantu, Slater, and Manzi. Claims 20, 23, and 24 have 9 The full text of claim 19 can be found in the Claims Appendix to the Appeal Brief (App. Br. 13). Appeal 2012-005177 Application 11/416,892 11 not been argued separately from claim 19, and therefore, fall with that claim. 37 C.F.R. § 41.37(c)(1)(vii). Conclusion of Law The preponderance of the evidence supports the Examiner’s conclusion that the combination of Felt, Cantu, Slater, and Manzi would have made obvious a method of spacing vertebral members within a patient comprising the step of “inserting a spacer through a cannula and into a disc space between the vertebral members . . . [wherein] the spacer is contained within a sheath and an end of the sheath is positioned on an exterior of the patient,” as required by claim 1. SUMMARY We affirm the rejection of claims 1, 2, 5–10, 12–14, 19, 20, 23, and 24 under 35 U.S.C. § 103(a). TIME PERIOD FOR RESPONSE No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED lp Copy with citationCopy as parenthetical citation